• Tidak ada hasil yang ditemukan

Profil Kadar Homosistein Serum pada Pasien Vitiligo di RSUP H. Adam Malik Medan

N/A
N/A
Protected

Academic year: 2017

Membagikan "Profil Kadar Homosistein Serum pada Pasien Vitiligo di RSUP H. Adam Malik Medan"

Copied!
6
0
0

Teks penuh

(1)

1. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol [Internet] 2011[ cited 2015 Oct 22];65:473-91. Available from:http://www.ncbi.nlm.nih.gov/ pubmed/ 21839315.

2. Birlea SA, Spritz RA, Noris DA. Vitiligo. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K,editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: The MCGraw-Hill companies. 2012. p. 1308-24.

3. Ezzedine K, Lifn HW, Suzuki T, Katayama I, Hamzavi I, Lan CCE, et al.Revised classification/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference . Pigment Cell Melanoma Res. 2012 May; 25(3): El-13. doi:10.1111/j.l755-148X.2012.00997.x. 3. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the

published work. Journal of Dermatology. 2011;38:419-31. doi: 10.111 1/j.1346-8138.2010.01139.x.

5. Gawkrodger DJ, Omerod AD, Shaw L, Mauri-sole I, Whitton ME, Watts MJ, et al.Guideline for the diagnosis and management of vitiligo. BJD. 2008; 159: 1051-76. doi: 10.1111/j.1365-2133.2008.08881.x.

6. Vrijman C, Homan MWL, Limpens J, Veen WVD, Wolkerstorfer AW, Terwee CB, et al. Measurement properties of outcome measures for vitiligo. Arch Dermatol [Internet]. 2012 [cited 2015 Oct 24]; 148(11): 1302-9.Available from:http://www.ncbi.nlm.nih.gov/pubmed/ 22986764. 7. Ping TW, KeE GB, lan TS, Kumarasinghe P. Clinical profile of vitiligo

in Singapore: an analysis over a 6-month period. Dermatology bulletin [ Internet]. 2007 [ cited 2015 Oct 26] ; September 18 (2): 19-23. Available from: https://www.nsc.coin.sg/Professional-Education/Documents/NSC- Bulletin-PDF/vol-18-no-2-2007.pdf.

8. Jusuf NK, Meher C. Pola Kelainan Pigmentasi di Poliklinik Kulit dan Kelamin Divisi Kosmetik RSUP H. Adam Malik Medan Tahun 2012-2015. Pertemuan Ilmiah Tahunan XV Ilmu Kesehatan Kulit dan Kelamin. Padang, Indonesia.

9. Rizal Y, Lestari S. Insidensi vitiligo di poliklinik kulit dan kelamin RSUP Dr. M Djamil Padang tahun 2001-2006. MDVI [Internet]. 2008 [cited 2015 Oct 26]; Januari 35 (1): 77. Available from: http://www.perdoski.org /index.php /public /information /mdvi-detail- content/77.

10. Spritz RA. Modern vitiligo genetics sheds new light on ancient disease. J Dermatol. 2013 May; 40(5): 1-15. doi:10.1111/1346-8138.12147.

(2)

52

12. Bolander-Gouaille C. Homocysteine, the new marker of disease risk-an overview. Business briefing: European pharmacotherapy. 2005;2-8. doi:10.1.1.199.9952.

13. Selhub J. Homocysteine metabolism. Annu. Rev Nutr. 1999; 19:217-46. doi:0199-9885/99/0715-0217$08.00.

14. Clarke S, Banfield K. S-Adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge. Cambridge university press; 2001.p. 63-78

15. Shaker OG, El-Tahlawi SMR. Is there a relationship between homocysteine and vitiligo? A pilot study. BJD. 2008; 159: 720-4. doi: 10.1111/J.1365-2133.2008.08712.X.

16. Juhlin L, Olsson MJ. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol. 1997; 77:460-2. doi:0001-5555.

17. Don P, iuga A, Dacko A, Hardick K. Treatment of vitiligo with broadband ultraviolet B and vitamins. Int J Dermatol [Internet]. 2006 [ cited 2015 Oct 23] ; 45:63-5. Available from: http://www.ncbi. nlm.nih. gov/pubmed/ 16426381.

18. Singh S, Singh U, Pandey SS. Serum folic acid, vitamin B12 and homocysteine levels in Indian vitiligo patients. EDOJ [ Internet]. 2012 June [ cited 2015 Oct 23]; 8(1):1-7. Available from: http :// www. edoj. org.eg/vol008/0801/002/01.htm.

19. Balci DD, Yunden Z, Yenin JZ, Okumus N. Serum homocysteine, folic acid and vitamin B12 levels in vitiligo. EJD. 2009 Jul-Aug; 19 (4): 382- 3. doi:10.1684/ejd.2009.0671.

20. Millington G W. M, Levell N J. Vitiligo: the historical curse of depigmentation. International Journal of Dermatology. 2007;46: 990-5. doi: 10.1111/j. 1365-4632.2007.03195.x.

21. Rahman MH, Amin MZ, Rahman M, Satter MA. A demographic study on vitiligo (sheti) in Bangladesh. Int J Res Med Sci. 2013; 1(2):123-8. doi: 10.5455/2320-6012.ijrms20130517.

22. Puri N, Phil M, Mojamdar M, Ramaiah A. In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects.The journal of investigative dermatology. 1987; 88(4): 434-8. doi: 0022- 202X/87/$03.50.

23. Spritz RA. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol. 2012;132: 268-73. doi: 10.1038/jid.2011.321.

24. Baum S, Barzilai A, Trau H. Vitiligo. In : Shoenfeld Y, Cervera R, Gershwin ME, editors. Diagnostic criteria in autoimmune diseases. Humana press [Internet]. 2008 [cited 2015 Oct 01].p. 353-8. Available from: http://link.springer.com/ book/ 10.1007%2F978-l-60327-285-8

(3)

unity. J Invest Dermatol. 2012; 132: 13-5. doi:10.103S /jid.201 1.353. 26. Wang CQF, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N.

Thl7 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One. 2011 April; 6(4): 1-11. doi: 10.1371/journal.pone.0018907 27. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an

aetiological factor in vitiligo. J Eur Acad Dermatol Venereol. 2007; 21: 865-876.doi: 10.1111/J.1468-3083.2007.02228.X.

28. Kemp EH, Emhemad S, Gawkrodger DJ, Weetman AP. Autoimmune disorders-pathogenic aspects. Chapter 14. p. 255-78.

29. Haider N, Islam MS, Al-Maraf A, Shohag MH, Ali R, Rahman GKMM, Hasnat A. Oxidative stress and antioxidant status in vitiligo patients. Dhaka Univ J Pharm Sci. 2010 Dec; 9(2): 103-8. doi: 10.3329/dujps.v9i2.7894.

30. Naini FF, Shooshtari AV, Ebrahimi B, Molaei R. The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: a pilot study. J Res Pharm Pract 2012; 1:77-80. doi: 10.4 103/2279-042X. 108375.

31. Shin JW, Nam KM, Choi HR, Huh SY, Kirn SW, Youn SW, et al. Erythrocyte malondialdehyde and glutathione levels in vitiligo patients. Ann Dermatol. 2010; 22(3): 279-83. doi: 10.5021/ad.2010.22.3.279. 32. Amin MZ, Rahman MH, Satter MA. Study of some biochemical

parameters of vitiligo patients in Bangladesh. Bangladesh J Sci Ind Res [ Internet]. 2012 [ cited 2015 Oct 20]; 47(2): 173-86. Available from: . http://www.banglajol.info/index.php/BJSIR /article/view II 1449.

33. Esmaeili B, Rezaee SAR, Layegh P, Afshari JT, Dye P, Karimiani EG, et al . Expression of IL-17 and COX2 gene in peripheral blood leukocytes of vitiligo patients. Iran J Allergy Asthma Immunol [Internet]. 2011 [cited 2015 Oct 1]; 10(2):81-9. Available from: http://www.sid.ir /en/VEWSSID/J_pdf/943201 10202.pdf.

34. Glassman SJ. Vitiligo, reactive oxygen species and T-cells. Clin Sci. 2011; 120: 99-120.doi: 10.1042/CS20090603.

35. Kamel N, Sobhy N, Kamal H, Ismail M. A comparative study of oxidant-antioxidant status in blood and tissue in vitiligo patients. EDOJ [Internet].2010 [cited 2015 Oct 1] ; 6(2): 1-10. Available from: http://www.edoj.org.eg/vol006/0602/002/paper.pdf.

36. Faria AR, Mira MT, Tarle RG, Castro CCS, Dellatore G. Vitiligo-part2 classification, histopathology and treatment. An Bras Dermatol. 2014;89(5):784-90.doi: 10.1590/abdl806-4841.20142717.

(4)

54

38. Brazelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow band phototherapy. J Eur Acad Dermatol Venereol. 2007;21:1369-74. doi: 10.1111/j.1468-3083.2007.02278.x.

39. Taieb A, Morice-Picard F, Jouary T, Ezzedine K, Cario^Andre M, Gauthier Y. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res. 2008; 21:646-52. doi: 10.1111/j. 1755- 148X.2008.00511.x.

40. Hann S, Chang J, Lee H, Kim S. The classification of segmental vitiligo on the face. Yonsei Med J [Internet]. 2000 [ cited 2015 Oct 22]; 41(2): 209-12. Available from:http://www.ncbi.nlm.nih.gov/pubmed/10817021. 41. Bhor U, Pande S. Scoring systems in dermatology. Indian J Dermatol

Venereol Leprol [serial online] 2006 [cited 2015 Nov 10];72:315-21. Available from: http://www.ijdvl. com/text.asp?2006/72/4/315/26722. 42. Alghamdi KM, Kumar A, Taieb A, Ezzedine K. Assessment methods for

the evaluation of vitiligo. JEADV. 2012;1-9. doi: 10.1111/j. 1468- 3083.2012.04505.x.

43.Taieb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res.2007; 20:27-35. doi: 10.1111/j.1600-0749.2006.00355.

44. Kawakami T, Hashimoto T. Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol Res Pract. 2011; 1-3. doi: 10.1155 72011/750342.

45. Al-mutairi N, Nour-Eldin O. Vitiligo treatment update. GJDV [Internet]. 2003 Oct [cited 2015 Oct 23] ;10 (2): 1-13. Available from: http://www. gulfdermaj ournal. com/pdf/2003 -10/1 .pdf.

46. Bordere AC, Lambert J, Geel NV. Current and emerging therapy for the management of vitiligo. Clin Cosmet Investig Dermatol [Internet]. 2009[cited 2015 Oct 25] ; 2: 15-25. Available from: http://www. ncbi .nlm. nih.gov/pmc/articles/PMC3047938/.

47. Felsten L, Alikhan A, Petronic-Rosic V. Vitiligo:A comprehensive overview part II: Treatment options and approach to treatment. J Am Acad Dermatol [Internet]. 2011[ cited 2015 Oct 22];65:493-514. Available from: http://www .ncbi.nlm. nih.gov/pubmed/21839316.

48. Clarke R. Lowering blood homocysteine with folic acid base supplements: meta-analysis of randomised trials. BMJ [Internet].

1998[cited 2015 Oct 2]; 894-8. Available from: http://www. ncbi.nlm.nih.gov/pmc/articles/PMC28491/pdt7894.pdf.

49. Yasar A, Gunduz K, Onur E, Calkan M. Serum homocysteine, vitamin B12, folic acid, levels and methylenetetrahtdrofolate reductase (MTHFR) gene polymorphism in vitiligo. Dis Markers. 2012; 33:85-9. doi: 10.3233/DMA-2012-0908..

(5)

50. Andre's E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ [Internet]. 2004 [cited 2015 Oct 1] ; 17(3): 251-9. Available from:http://www.researchgate.net/profile/Frederic_Maloisel/publicatio n/8421627_Vitamin_B12_(cobalamin)_deficiency_in_elderly_patients /links/OOb49 52289e7cc6179000000.pdf.

51. Hustad S, Ueland PM, Vollset SE, Zhang Y, Bj0rke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the rnethylenetetrahydrofolate reductase C677T polymorphism. Clin Chem [ Internet]. 2000 [ cited 2015 Oct 25]; May 46 (8): 1065-71. Available from: http://www .clinchem . org/content/46/8/1065. Long.

52. Ubbink JB, Vermaak WJH, Merwe AVD, Becker PJ. Vitamin B- 12,vitamin b-6, and folate nutritional status in men withhyperhomocysteinemia. Am J Clin Nutr [Internet]. 1993 [ cited 2015 Oct23] ; 57: 47-53. Availabe from: http://ajcn. nutrition, org/ content' /57/l/47.1ong.

53. Bailey LB, Gregory JF. Folate metabolism and requirements. J. Nutr [Internet]. 1999 [cited 2015 Oct 27]; 129: 779-82. Available from: http://jn.nutrition.org/content/129/4/779.full.pdf+html.

54. Sabry HH, Sabry JH, Hashim HM. Serum levels of homocysteine, vitamin B12, and folic acid in vitiligo. Egypt J Dermatol Venerol [Internet] 2014 [cited 2015 Nov 27];34:65-9. Available from: http://www.ejdv.eg.net/text.asp?2014/34/l/65/137315.

55. Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: A pilot study. J Am Acad Dermatbl. 2011. 64(2): 445-7. doi: 10.1016/j,jaad.2010.08.025.

56. Ghalamkarpour F Jafarian Z, Einollahi H, Younespour S. Homocysteine: is it a biomarker for vitiligo? Journal of pigmentary disorders. 2015; 2(4): 1-4. doi: 10.4172/2376-0427.1000172.

57. Yasar A, Gunduz K, Onur E, Calkan M. Serum homocysteine, vitamin B12, folic acid levels and methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in vitiligo. Disease markers. 2012; 33: 85-9. Doi: 10.3233/DMA-2012-0908.

58. Yu H, Chang K, Yu C, Li H, Wu M, Wu C,et al. Alterations in IL-6, IL-8, GM-CSF, TNF-a, and IFNy release by peripheral mononuclear cells in patients with active vitiligo. J invest Dermatol. 1997.108: 527-9. doi: 10.111 l/1523-1747.ep12289743.

59. Becatti M, Prigano F, Fiorillo, Pescitelli L, Nassi P, Lotti T, Taddei N.The involvement of Smac/DIABLO, p53,NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligft skin: protective effects of curcumin and capsaicin. Antioxidants & Redox Signaling. 2010; 13(9): 1309-21. doi: 10.1089/ars.2009.2779.

60. Silverberg NB. The Epidemiology of Vitiligo. Curr Derm Rep. 2015 Januari; 4:36–43.doi: 10.1007/s13671-014-0098-6.

(6)

56 62. Jha BN. Assessment of Prevalence of Clinical and Sociodemographic

Study of Vitiligo in Janaki Medical College, Nepal. 2016 Februari;ARJLS. 2(2):1 – 4. ISSN: 2455-3549.

63. Wang X, et al. Prevalence and Clinical Profile of Vitiligo in China: A Community based Study in Six Cities. Acta Derm Venereol 2013; 93: 62–5. doi: 10.2340/00015555-1397.

64. Patil S, Gautam M, Nadkarni N, Saboo N, Godse K, Setia MS. Gender Differences in Clinicoepidemiological Features of Vitiligo: A Cross-Sectional Analysis. ISRN Dermatology. 2014 Feb;1-6. doi: 10.1155/2014/186197.

65. Zaki AM, Abdo HM, Ibrahim IM, Ibrahim AEKI. Serum homocysteine and vitiligo. The gulf journal of dermatology and venereology[Internet]. 2014[ cited 2015 Nov 29] ; 21(2): 15-20. Availble from: https://www. google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=0ah UKEwjzy8p1cnKAhVBBY4KHQnjB1EQFggrMAI&url=http%3A%2F %2Fwww.gulfdermajournal.com%2Fpdf%2F201410%2F2.pdf&usg=AF QjCNGXyvhhvl6trAe0SHRVAImXn0Yi1g&sig2=5MUvJNMVGIU_eS 1rBkBO7A&cad=rj

66. Koehler KM, Baum RG, Gary PJ, Allen RH, Stabler SP, Rimm EB. Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use. Am J Clin Nutr. 2001 March ; 73:628–37. PMID:11237942.

67. Agarwal S, Mendiratta V, Chander R, Jain A, Yadav P. Study of serum levels of Vitamin B, folic acid, and homocysteine in vitiligo. Pigment Int 2015;2:76-80. doi: 10.4103/2349-5847.172777

Referensi

Dokumen terkait

antara tes kemampuan matematika dasar untuk pretest dan posttest, sehingga dapat disimpulkan bahwa ada pengaruh penggunaan metode ekspositori pada pembelajaran mata

UNFPA bangga telah berkontribusi dalam penyusunan buku saku ini dengan memberikan bantuan teknis kepada Kementerian Kesehatan dan ARI dan berharap bahwa buku saku ini akan

KEGIATAN PROGRAM INDONESIA SEHAT DENGAN PENDEKATAN KELUARGA DI PROVINSI JAWA BARAT.

Selanjutnya, dalam buku pedoman pelatihan “Peningkatan Kompetensi Kepala Sekolah dalam Mengelola Implementasi Kurikulum: Evaluasi Diri Sekolah” dikemukakan bahwa EDS

Kategori verba kejadian dalam kajian ini diilustrasikan dengan komponen semantis ‘sesuatu terjadi pada sesuatu/seseorang karena seseorang yang lain melakukan sesuatu’.. Verba

Abstrak: Penelitian kualitatif ini mendeskripsikan metakognisi mahasiswa perempuan dengan gaya kognitif reflektif dan impulsif dalam menyelesaikan masalah bangun datar. Subjek

Mengingat upaya peningkatan kesehatan reproduksi dilaksanakan melalui pendekatan siklus hidup, dimana kebutuhan akan pelayanan kesehatan untuk setiap tahapan individu

Struktur Semantik Verba Proses Tipe Kejadian Bahasa Jawa: Kajian.. Metabahasa